Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Fibrosin Inhibitors

Fibrosin inhibitors generally operate by disrupting crucial cellular signaling pathways. Many target the cell growth, differentiation, and proliferation processes; compounds such as All-trans Retinoic Acid and 5-Fluorouracil can affect the functional activity of Fibrosin by influencing these cellular processes, reducing the requirement for Fibrosin in cell growth and proliferation or disturbing the cell cycle progression where Fibrosin is involved respectively. This method of action effectively disrupts the cell proliferation and differentiation processes, leading to the indirect impairment of Fibrosin.

Simultaneously, Fibrosin inhibitors may target various signaling pathways, of which Fibrosin is a part. Inhibitors such as Staurosporine, Genistein, PD98059, U0126, LY294002, SB203580, SP600125, and Y-27632 are potent inhibitors of various kinases and pathways that redcues the regular functioning of these pathways, thus indirectly inhibiting Fibrosin. For instance, Staurosporine's inhibition of Protein Kinase C (PKC) and Genistein's inhibition of tyrosine kinases can disrupt signaling pathways involving Fibrosin, leading to its functional inhibition. Therefore, by disrupting these key signaling pathways, the inhibitors can indirectly suppress Fibrosin's activity.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

All-trans Retinoic Acid is involved in the regulation of cell proliferation and differentiation. It can affect the functional activity of Fibrosin by promoting cellular differentiation, thus potentially reducing the requirement for Fibrosin in cell growth and proliferation.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$37.00
$152.00
11
(1)

5-Fluorouracil is a pyrimidine analog that disrupts nucleotide synthesis, which can indirectly inhibit Fibrosin by disturbing the cell cycle progression and proliferation where Fibrosin is involved.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Staurosporine is a potent inhibitor of Protein Kinase C (PKC), which might disrupt downstream signaling pathways involving Fibrosin, leading to its functional inhibition.

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$176.00
$426.00
43
(3)

Doxorubicin intercalates into DNA, disrupting the cell cycle. This can lead to the indirect inhibition of Fibrosin by altering cellular proliferation processes.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$51.00
$231.00
$523.00
63
(1)

Etoposide inhibits topoisomerase II, resulting in DNA damage and cell cycle arrest, which can indirectly inhibit Fibrosin by affecting cellular proliferation.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Genistein is a tyrosine kinase inhibitor. Its inhibition of tyrosine kinases can disrupt signaling pathways involving Fibrosin, leading to its functional inhibition.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is a selective inhibitor of MEK, a kinase directly upstream of the ERK pathway. Its inhibition of the ERK pathway might lead to the functional inhibition of Fibrosin, which is involved in this pathway.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor that disrupts the PI3K/AKT pathway, which may indirectly inhibit Fibrosin, considering its role in this pathway.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a potent inhibitor of p38 MAPK, which might disrupt downstream signaling pathways involving Fibrosin, leading to its functional inhibition.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is a selective inhibitor of JNK MAPK, which might disrupt downstream signaling pathways involving Fibrosin, leading to its functional inhibition.